Vimarsana
Biggest News Aggregation in the World

Without Concurrent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Without Concurrent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Without Concurrent Today - Breaking & Trending Today

Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in NSCLC Patients with MetExon14 Skipping Mutation - Vimarsana News

Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in NSCLC Patients with MetExon14 Skipping Mutation

Treatment of NSCLC patients with MetExon14 skipping mutation with and without co-occurring MET amplification, reflecting “real-world”1 setting FOSTER CITY, Calif., Dec. 04, 2023 -- Apollomics...

Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC) - Vimarsana News

Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)

FOSTER CITY, Calif., Nov. 28, 2023 -- Apollomics Inc. , a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and...

Apollomics Announces Presentation of Vebreltinib Data at - Vimarsana News

Apollomics Announces Presentation of Vebreltinib Data at

FOSTER CITY, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (the “Company”), a late-stage clinical biopharmaceutical company...